Health Policy and Patient Education

Health policies influence everything from medication prices and insurance coverage to how people access and manage their care. The Health Policy and Patient Education category turns complex legislative updates and healthcare reforms into clear, actionable insights that everyday readers can use.

Each article in this section breaks down what new rules mean for patients and advocates—whether it’s a Medicare change, drug pricing reform, or coverage expansion—and connects policy updates to real-world healthcare navigation. Readers learn not only what changed, but how to respond, ask informed questions, and make smarter care decisions.

By blending health policy awareness with strong patient education principles, this category helps consumers, caregivers, and advocates gain the confidence and navigation skills they need to thrive in today’s evolving healthcare system.

Value-based care explained through patient-centered healthcare, showing a physician and care team engaging with an older patient and caregiver to support coordinated, outcome-focused care.
Health Policy and Patient Education

Value-Based Care Explained: Why U.S. Healthcare Is Shifting From Volume to Outcomes—and What That Means for Patients

Value-based care is reshaping how healthcare is delivered, measured, and paid for—but most patients are never told what that actually means for their care. This article explains value-based care in plain language so you can understand the system shift, why patient engagement matters, and how this model affects access, outcomes, and everyday healthcare decisions.

Doctor measuring an older patient’s waist during a consultation about the Trump drug pricing deal and new Medicare coverage for weight-loss medications.
Health Policy and Patient Education

Trump Drug Pricing Deal with Dr. Mehmet Oz: Understanding the New Rules for Wegovy, Ozempic, and Medicare Patients

Breaking news — November 6, 2025, 10 a.m. ET: President Donald Trump and CMS Administrator Dr. Mehmet Oz announced a new Trump drug pricing deal with Eli Lilly and Novo Nordisk to cut the cost of popular weight-loss drugs, including Wegovy and Ozempic. The plan introduces Medicare copays as low as $50 a month and a new TrumpRx platform for direct patient access. Here’s what this means for health advocates, patients, and the future of medication affordability.

Scroll to Top